Hyperthermia / HSP72 Cancer Research Results

HPT, Hyperthermia: Click to Expand ⟱

Features:

Mild Hyperthermia (Approximately 39°C to 41°C
Pathways and Effects:
-Heat Shock Protein (HSP) Induction: Mild heat stress triggers the production of HSPs (e.g., HSP70, HSP90) that help cells cope with stress, which can sometimes provide a transient protective effect. However, these proteins can also act as immunomodulators.
-Modulation of the Immune System: Mild hyperthermia can enhance dendritic cell activation and improve antigen presentation, leading to the stimulation of anti-tumor immune responses.
-Vasodilation: Increased blood flow and improved oxygenation can sensitize tumors to radiation therapy and certain chemotherapeutics.

Moderate Hyperthermia (Approximately 41°C to 43°C)
Pathways and Effects:
-Enhanced Cytotoxicity: At temperatures in this range, tumor cells become more vulnerable to radiation and some chemotherapeutic agents. This is partly due to the inhibition of DNA repair pathways.
-Increased Permeability: Moderate heat can increase the permeability of cellular membranes, aiding in drug delivery and the uptake of chemotherapeutic agents.
-Induction of Apoptosis: Elevated temperatures can trigger apoptotic signaling pathways in cancer cells, sometimes in conjunction with other therapies.

High Hyperthermia / Thermal Ablation (Approximately 43°C to 50°C and above)
Pathways and Effects:
-Direct Cytotoxicity: High temperatures can lead to protein denaturation, membrane disruption, and direct cell death.
-Coagulative Necrosis: Sustained high temperatures cause irreversible cell injury leading to necrosis of tumor tissues.
-Vascular Damage: Hyperthermia in this range can damage tumor vasculature, reducing blood supply and indirectly causing tumor cell death.
-Enhanced Immune Response: Although high temperatures can cause immediate cell death, the release of tumor antigens and damage-associated molecular patterns (DAMPs) can stimulate an anti-tumor immune response

Rank	Pathway / Axis	Cancer / Tumor Context	Normal Tissue Context	TSF	Primary Effect	Notes / Interpretation
1	Proteotoxic stress / protein denaturation	Misfolded protein burden ↑; proteostasis overload ↑	Heat stress response (tolerance higher if well-perfused)	P, R	Core physical stressor	Direct heat disrupts protein folding and complex stability; tumors can be more vulnerable due to baseline stress and poor perfusion.
2	Heat Shock Response (HSF1 → HSPs)	HSP70/HSP90 ↑; stress tolerance ↑ (can be protective)	HSP induction ↑ (protective)	R, G	Adaptive survival program	HSP induction is a major adaptation; can blunt repeated heat exposures and is a key reason scheduling matters.
3	DNA damage repair inhibition / radiosensitization	HR repair ↓; DNA repair capacity ↓ (reported)	↔ (tissue-dependent)	R	Sensitization to radiation	Hyperthermia can impair DNA repair processes (notably homologous recombination), increasing radiation effectiveness when timed appropriately.
4	Tumor perfusion / oxygenation changes	Perfusion ↑ (often) → oxygenation ↑; hypoxia ↓ (context)	Perfusion ↑	P, R	Microenvironment modulation	Improved perfusion can increase oxygenation (helping radiotherapy) and improve delivery of some drugs; effects depend on local vascular state.
5	Cell membrane / cytoskeleton disruption	Membrane permeability ↑; cytoskeletal stress ↑	↔ / injury possible at higher exposures	P, R	Physical cell stress	Heat can increase permeability and alter membrane trafficking; contributes to drug uptake in some settings.
6	Intrinsic apoptosis / necrosis (dose-dependent)	Apoptosis ↑ or necrosis ↑ at higher thermal dose	Collateral injury risk if overdosed	R, G	Direct cytotoxicity (thermal dose dependent)	At moderate hyperthermia, sensitization dominates; at higher thermal dose, direct cell killing becomes more prominent.
7	Immune activation / DAMP release (ICD-like signals)	DAMPs ↑; antigen presentation ↑ (reported)	—	G	Immune support	Heat stress and tumor cell damage can release DAMPs and promote immune visibility; strength varies by regimen and tumor type.
8	Vascular effects (edema, vessel damage) at higher dose	Vascular injury ↑ at higher thermal dose	Normal tissue injury risk ↑	R, G	Toxicity / local control effects	At higher temperatures or prolonged exposure, vascular damage contributes to tumor control but increases normal tissue risk.
9	Chemo-sensitization (drug delivery + stress synergy)	Drug uptake ↑; cytotoxic synergy ↑ (reported)	Systemic toxicity may ↑ depending on regimen	R, G	Combination leverage	Heat can potentiate some agents (e.g., platinum drugs) and improve delivery; regimen-specific.
10	Thermal dose / parameter dependence (time×temp)	Outcome depends on temperature, duration, targeting, and timing vs RT/chemo	Safety depends on precision and monitoring	—	Translation constraint	Hyperthermia is highly dose-dependent; “too little” yields little sensitization, “too much” increases burns/necrosis risk.

Time-Scale Flag (TSF): P / R / G

P: 0–30 min (direct heat stress; perfusion/permeability shifts begin)
R: 30 min–3 hr (HSP induction; DNA repair suppression; apoptosis initiation)
G: >3 hr (phenotype outcomes: immune effects, sensitization results, tissue injury)

HSP72, Heat Shock Protein 72: Click to Expand ⟱

Source:

Type:

Also known as HSPA1A
HSP72, or Heat Shock Protein 72, is a member of the heat shock protein family, which plays a crucial role in cellular stress responses. It is also known as HSPA1A and is involved in protein folding, protection against stress-induced damage, and the regulation of apoptosis (programmed cell death). HSP72 can help cancer cells survive under stressful conditions, such as those found in the tumor microenvironment (e.g., low oxygen, nutrient deprivation). This ability to protect cells from stress can contribute to tumor growth and resistance to therapy.
Elevated levels of HSP72 have been associated with resistance to various cancer treatments, including chemotherapy and radiation. Cancer cells that express high levels of HSP72 may be more capable of repairing damage caused by these therapies, leading to treatment failure.

Scientific Papers found: Click to Expand⟱

97-

QC,

HPT,

Effects of the flavonoid drug Quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo

in-vitro,

Pca,

PC3

 0-400 uM; 150mg/kg/day

HSP72↑, TumCG↓, eff↑, ChemoSen↑, RadioS↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Protein Folding & ER Stress ⓘ

HSP72↑, 1,

Proliferation, Differentiation & Cell State ⓘ

TumCG↓, 1,

Drug Metabolism & Resistance ⓘ

ChemoSen↑, 1, eff↑, 1, RadioS↑, 1,
Total Targets: 5

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: HSP72, Heat Shock Protein 72

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells